alizarin has been researched along with Fatty Liver, Nonalcoholic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Borén, J; Brear, P; Foller Füchtbauer, A; Gao, C; Grøtli, M; Håversen, L; Hyvönen, M; Kim, W; Lulla, A; Mardinoglu, A; Matic, J; Monjas, L; Nain-Perez, A; Rodríguez, A; Uhlen, M | 1 |
1 other study(ies) available for alizarin and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase.
Topics: Adenosine Diphosphate; Anthraquinones; Humans; Liver; Non-alcoholic Fatty Liver Disease; Pyruvate Kinase | 2022 |